AU2004236573B2

AU2004236573B2 - Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues

Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues Download PDF

Info

Publication number: AU2004236573B2
Authority: AU; Australia
Prior art keywords: pdx; cell; pancreatic; expression; insulin
Prior art date: 2003-05-12
Legal status : Expired

Application number

AU2004236573A

Other languages

English (en)

Other versions

AU2004236573A1 (en

Inventor

Sarah Ferber

Current Assignee

Individual

Original Assignee

Individual

Priority date

2003-05-12

Filing date

2004-05-12

Publication date

2009-10-22

2004-05-12 Application filed by Individual filed Critical Individual

2004-11-18 Publication of AU2004236573A1 publication Critical patent/AU2004236573A1/en

2009-10-22 Application granted granted Critical

2009-10-22 Publication of AU2004236573B2 publication Critical patent/AU2004236573B2/en

2024-05-12 Anticipated expiration legal-status Critical

Status Expired legal-status Critical Current

Links

238000000034 method Methods 0.000 title claims description 133
210000004153 islets of langerhan Anatomy 0.000 title claims description 46
230000001939 inductive effect Effects 0.000 title claims description 27
230000001105 regulatory effect Effects 0.000 title description 42
102000052651 Pancreatic hormone Human genes 0.000 title description 40
239000004025 pancreas hormone Substances 0.000 title description 40
229940032957 pancreatic hormone Drugs 0.000 title description 40
238000004519 manufacturing process Methods 0.000 title description 39
101800001268 Pancreatic hormone Proteins 0.000 title description 23
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims description 367
210000004027 cell Anatomy 0.000 claims description 326
230000014509 gene expression Effects 0.000 claims description 271
108090001061 Insulin Proteins 0.000 claims description 188
229940125396 insulin Drugs 0.000 claims description 184
102000004877 Insulin Human genes 0.000 claims description 183
108090000623 proteins and genes Proteins 0.000 claims description 113
210000005229 liver cell Anatomy 0.000 claims description 107
241000282414 Homo sapiens Species 0.000 claims description 74
101100519293 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pdx-1 gene Proteins 0.000 claims description 48
206010012601 diabetes mellitus Diseases 0.000 claims description 45
230000002440 hepatic effect Effects 0.000 claims description 43
108060003199 Glucagon Proteins 0.000 claims description 35
229960004666 glucagon Drugs 0.000 claims description 34
MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 claims description 34
108010056088 Somatostatin Proteins 0.000 claims description 32
238000000338 in vitro Methods 0.000 claims description 32
239000003102 growth factor Substances 0.000 claims description 31
102000005157 Somatostatin Human genes 0.000 claims description 30
239000000203 mixture Substances 0.000 claims description 30
229960000553 somatostatin Drugs 0.000 claims description 29
NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 claims description 29
108090000765 processed proteins & peptides Proteins 0.000 claims description 25
210000002966 serum Anatomy 0.000 claims description 24
230000002124 endocrine Effects 0.000 claims description 21
102400001242 Betacellulin Human genes 0.000 claims description 20
101800001382 Betacellulin Proteins 0.000 claims description 20
102000004196 processed proteins & peptides Human genes 0.000 claims description 20
108091023040 Transcription factor Proteins 0.000 claims description 18
102000040945 Transcription factor Human genes 0.000 claims description 18
-1 Ngn3.1 Proteins 0.000 claims description 17
239000003795 chemical substances by application Substances 0.000 claims description 17
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 16
101150079937 NEUROD1 gene Proteins 0.000 claims description 15
229920001184 polypeptide Polymers 0.000 claims description 15
238000001890 transfection Methods 0.000 claims description 13
VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims description 13
102400001368 Epidermal growth factor Human genes 0.000 claims description 12
101800003838 Epidermal growth factor Proteins 0.000 claims description 12
102100041030 Pancreas/duodenum homeobox protein 1 Human genes 0.000 claims description 12
229940116977 epidermal growth factor Drugs 0.000 claims description 12
239000003550 marker Substances 0.000 claims description 10
238000001990 intravenous administration Methods 0.000 claims description 9
108010088751 Albumins Proteins 0.000 claims description 7
101710144033 Pancreas/duodenum homeobox protein 1 Proteins 0.000 claims description 6
210000002798 bone marrow cell Anatomy 0.000 claims description 6
102100032063 Neurogenic differentiation factor 1 Human genes 0.000 claims description 5
108050000588 Neurogenic differentiation factor 1 Proteins 0.000 claims description 5
238000007912 intraperitoneal administration Methods 0.000 claims description 5
210000004927 skin cell Anatomy 0.000 claims description 5
238000007920 subcutaneous administration Methods 0.000 claims description 5
108700014808 Homeobox Protein Nkx-2.2 Proteins 0.000 claims description 4
102100028098 Homeobox protein Nkx-6.1 Human genes 0.000 claims description 4
101000578254 Homo sapiens Homeobox protein Nkx-6.1 Proteins 0.000 claims description 4
102000016997 Lithostathine Human genes 0.000 claims description 4
108010014691 Lithostathine Proteins 0.000 claims description 4
208000016222 Pancreatic disease Diseases 0.000 claims description 4
108010067372 Pancreatic elastase Proteins 0.000 claims description 4
102000016387 Pancreatic elastase Human genes 0.000 claims description 4
FQVLRGLGWNWPSS-BXBUPLCLSA-N (4r,7s,10s,13s,16r)-16-acetamido-13-(1h-imidazol-5-ylmethyl)-10-methyl-6,9,12,15-tetraoxo-7-propan-2-yl-1,2-dithia-5,8,11,14-tetrazacycloheptadecane-4-carboxamide Chemical compound N1C(=O)[C@@H](NC(C)=O)CSSC[C@@H](C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CC1=CN=CN1 FQVLRGLGWNWPSS-BXBUPLCLSA-N 0.000 claims description 3
229940125668 ADH-1 Drugs 0.000 claims description 3
102100033830 Amphiphysin Human genes 0.000 claims description 3
101000796901 Gallus gallus Alcohol dehydrogenase 1 Proteins 0.000 claims description 3
101100180055 Gallus gallus ISL2 gene Proteins 0.000 claims description 3
101000779845 Homo sapiens Amphiphysin Proteins 0.000 claims description 3
101000962041 Homo sapiens Neurobeachin Proteins 0.000 claims description 3
101000591210 Homo sapiens Receptor-type tyrosine-protein phosphatase-like N Proteins 0.000 claims description 3
101100460498 Mus musculus Nkx2-2 gene Proteins 0.000 claims description 3
102100039234 Neurobeachin Human genes 0.000 claims description 3
101000832889 Scheffersomyces stipitis (strain ATCC 58785 / CBS 6054 / NBRC 10063 / NRRL Y-11545) Alcohol dehydrogenase 2 Proteins 0.000 claims description 3
DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims description 3
108010023082 activin A Proteins 0.000 claims description 3
208000024691 pancreas disease Diseases 0.000 claims description 3
102100031192 Chondroitin sulfate N-acetylgalactosaminyltransferase 1 Human genes 0.000 claims description 2
101100220368 Homo sapiens CSGALNACT1 gene Proteins 0.000 claims description 2
101000873676 Homo sapiens Secretogranin-2 Proteins 0.000 claims description 2
101001077660 Homo sapiens Serine protease inhibitor Kazal-type 1 Proteins 0.000 claims description 2
101100013973 Mus musculus Gata4 gene Proteins 0.000 claims description 2
102100034091 Receptor-type tyrosine-protein phosphatase-like N Human genes 0.000 claims description 2
102100025144 Serine protease inhibitor Kazal-type 1 Human genes 0.000 claims description 2
102000009027 Albumins Human genes 0.000 claims 1
108010003471 Fetal Proteins Proteins 0.000 claims 1
102000004641 Fetal Proteins Human genes 0.000 claims 1
102400000321 Glucagon Human genes 0.000 claims 1
102100030550 Menin Human genes 0.000 claims 1
101000989950 Otolemur crassicaudatus Hemoglobin subunit alpha-A Proteins 0.000 claims 1
101001032756 Rattus norvegicus Granzyme-like protein 1 Proteins 0.000 claims 1
241000283984 Rodentia Species 0.000 claims 1
230000037317 transdermal delivery Effects 0.000 claims 1
241000699670 Mus sp. Species 0.000 description 147
210000004185 liver Anatomy 0.000 description 124
150000007523 nucleic acids Chemical class 0.000 description 91
102000039446 nucleic acids Human genes 0.000 description 90
108020004707 nucleic acids Proteins 0.000 description 90
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 77
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 76
239000008103 glucose Substances 0.000 description 74
150000001875 compounds Chemical class 0.000 description 64
238000011282 treatment Methods 0.000 description 62
241000701161 unidentified adenovirus Species 0.000 description 49
210000001519 tissue Anatomy 0.000 description 48
239000013598 vector Substances 0.000 description 41
210000000496 pancreas Anatomy 0.000 description 40
102000004169 proteins and genes Human genes 0.000 description 40
241000700159 Rattus Species 0.000 description 39
239000002933 immunoreactive insulin Substances 0.000 description 38
235000018102 proteins Nutrition 0.000 description 36
102000051325 Glucagon Human genes 0.000 description 33
230000028327 secretion Effects 0.000 description 33
239000013604 expression vector Substances 0.000 description 32
108020004414 DNA Proteins 0.000 description 30
210000004369 blood Anatomy 0.000 description 29
239000008280 blood Substances 0.000 description 29
230000000694 effects Effects 0.000 description 29
238000003127 radioimmunoassay Methods 0.000 description 27
VOUAQYXWVJDEQY-QENPJCQMSA-N 33017-11-7 Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 VOUAQYXWVJDEQY-QENPJCQMSA-N 0.000 description 26
101000976075 Homo sapiens Insulin Proteins 0.000 description 26
241000699666 Mus <mouse, genus> Species 0.000 description 24
230000006870 function Effects 0.000 description 24
230000006698 induction Effects 0.000 description 24
238000001727 in vivo Methods 0.000 description 23
230000001225 therapeutic effect Effects 0.000 description 23
PBGKTOXHQIOBKM-FHFVDXKLSA-N insulin (human) Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 PBGKTOXHQIOBKM-FHFVDXKLSA-N 0.000 description 22
230000001605 fetal effect Effects 0.000 description 21
230000008569 process Effects 0.000 description 21
238000003757 reverse transcription PCR Methods 0.000 description 21
ZSJLQEPLLKMAKR-GKHCUFPYSA-N streptozocin Chemical compound O=NN(C)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O ZSJLQEPLLKMAKR-GKHCUFPYSA-N 0.000 description 21
201000001421 hyperglycemia Diseases 0.000 description 19
238000002347 injection Methods 0.000 description 19
239000007924 injection Substances 0.000 description 19
239000000243 solution Substances 0.000 description 19
108010075254 C-Peptide Proteins 0.000 description 18
238000004458 analytical method Methods 0.000 description 18
229940088597 hormone Drugs 0.000 description 18
239000005556 hormone Substances 0.000 description 18
230000004044 response Effects 0.000 description 18
108091032973 (ribonucleotides)n+m Proteins 0.000 description 17
108700020479 Pancreatic hormone Proteins 0.000 description 17
210000003494 hepatocyte Anatomy 0.000 description 17
239000013615 primer Substances 0.000 description 17
238000012360 testing method Methods 0.000 description 17
241000700605 Viruses Species 0.000 description 16
238000001514 detection method Methods 0.000 description 16
230000001965 increasing effect Effects 0.000 description 16
208000015181 infectious disease Diseases 0.000 description 16
239000000284 extract Substances 0.000 description 15
230000003612 virological effect Effects 0.000 description 15
241001465754 Metazoa Species 0.000 description 14
230000003914 insulin secretion Effects 0.000 description 14
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
239000002299 complementary DNA Substances 0.000 description 13
238000001415 gene therapy Methods 0.000 description 13
210000003734 kidney Anatomy 0.000 description 13
239000000047 product Substances 0.000 description 13
208000035475 disorder Diseases 0.000 description 12
238000002474 experimental method Methods 0.000 description 12
108020004999 messenger RNA Proteins 0.000 description 12
239000000523 sample Substances 0.000 description 12
230000004913 activation Effects 0.000 description 11
239000005090 green fluorescent protein Substances 0.000 description 11
108700011804 pancreatic and duodenal homeobox 1 Proteins 0.000 description 11
239000008194 pharmaceutical composition Substances 0.000 description 11
230000004927 fusion Effects 0.000 description 10
239000000411 inducer Substances 0.000 description 10
239000013612 plasmid Substances 0.000 description 10
210000003462 vein Anatomy 0.000 description 10
102100027211 Albumin Human genes 0.000 description 9
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 9
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 9
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 9
239000003814 drug Substances 0.000 description 9
230000005014 ectopic expression Effects 0.000 description 9
238000011534 incubation Methods 0.000 description 9
239000000463 material Substances 0.000 description 9
230000001404 mediated effect Effects 0.000 description 9
238000012545 processing Methods 0.000 description 9
210000004739 secretory vesicle Anatomy 0.000 description 9
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 8
DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 8
108010076181 Proinsulin Proteins 0.000 description 8
108700019146 Transgenes Proteins 0.000 description 8
238000006243 chemical reaction Methods 0.000 description 8
238000009472 formulation Methods 0.000 description 8
210000002510 keratinocyte Anatomy 0.000 description 8
238000003259 recombinant expression Methods 0.000 description 8
230000009885 systemic effect Effects 0.000 description 8
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
101001128694 Homo sapiens Neuroendocrine convertase 1 Proteins 0.000 description 7
102100032132 Neuroendocrine convertase 1 Human genes 0.000 description 7
238000010240 RT-PCR analysis Methods 0.000 description 7
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 7
230000004075 alteration Effects 0.000 description 7
230000003321 amplification Effects 0.000 description 7
230000000692 anti-sense effect Effects 0.000 description 7
230000037396 body weight Effects 0.000 description 7
239000002775 capsule Substances 0.000 description 7
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 7
231100000673 dose–response relationship Toxicity 0.000 description 7
239000002502 liposome Substances 0.000 description 7
210000005228 liver tissue Anatomy 0.000 description 7
210000004962 mammalian cell Anatomy 0.000 description 7
238000003199 nucleic acid amplification method Methods 0.000 description 7
239000002953 phosphate buffered saline Substances 0.000 description 7
238000002360 preparation method Methods 0.000 description 7
238000003753 real-time PCR Methods 0.000 description 7
238000010186 staining Methods 0.000 description 7
210000000130 stem cell Anatomy 0.000 description 7
238000012384 transportation and delivery Methods 0.000 description 7
239000013603 viral vector Substances 0.000 description 7
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
241000588724 Escherichia coli Species 0.000 description 6
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
239000013614 RNA sample Substances 0.000 description 6
101000999001 Rattus norvegicus Insulin-1 Proteins 0.000 description 6
238000000137 annealing Methods 0.000 description 6
238000004925 denaturation Methods 0.000 description 6
230000036425 denaturation Effects 0.000 description 6
239000003937 drug carrier Substances 0.000 description 6
238000002513 implantation Methods 0.000 description 6
230000003834 intracellular effect Effects 0.000 description 6
125000003729 nucleotide group Chemical group 0.000 description 6
238000011160 research Methods 0.000 description 6
210000000952 spleen Anatomy 0.000 description 6
238000003860 storage Methods 0.000 description 6
238000012546 transfer Methods 0.000 description 6
VRYALKFFQXWPIH-PBXRRBTRSA-N (3r,4s,5r)-3,4,5,6-tetrahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)CC=O VRYALKFFQXWPIH-PBXRRBTRSA-N 0.000 description 5
102000053602 DNA Human genes 0.000 description 5
108010043121 Green Fluorescent Proteins Proteins 0.000 description 5
102000004144 Green Fluorescent Proteins Human genes 0.000 description 5
108091028043 Nucleic acid sequence Proteins 0.000 description 5
108091034117 Oligonucleotide Proteins 0.000 description 5
108090000544 Proprotein convertase 1 Proteins 0.000 description 5
102000004085 Proprotein convertase 1 Human genes 0.000 description 5
239000004480 active ingredient Substances 0.000 description 5
PMMURAAUARKVCB-UHFFFAOYSA-N alpha-D-ara-dHexp Natural products OCC1OC(O)CC(O)C1O PMMURAAUARKVCB-UHFFFAOYSA-N 0.000 description 5
238000009739 binding Methods 0.000 description 5
230000000903 blocking effect Effects 0.000 description 5
239000000969 carrier Substances 0.000 description 5
230000004069 differentiation Effects 0.000 description 5
230000002183 duodenal effect Effects 0.000 description 5
210000003890 endocrine cell Anatomy 0.000 description 5
239000012634 fragment Substances 0.000 description 5
238000001476 gene delivery Methods 0.000 description 5
238000004128 high performance liquid chromatography Methods 0.000 description 5
230000003345 hyperglycaemic effect Effects 0.000 description 5
239000004615 ingredient Substances 0.000 description 5
230000003908 liver function Effects 0.000 description 5
230000014759 maintenance of location Effects 0.000 description 5
239000002773 nucleotide Substances 0.000 description 5
210000000056 organ Anatomy 0.000 description 5
230000037361 pathway Effects 0.000 description 5
210000003491 skin Anatomy 0.000 description 5
230000001052 transient effect Effects 0.000 description 5
230000014616 translation Effects 0.000 description 5
CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
241000700199 Cavia porcellus Species 0.000 description 4
238000000018 DNA microarray Methods 0.000 description 4
241000238631 Hexapoda Species 0.000 description 4
101000612089 Homo sapiens Pancreas/duodenum homeobox protein 1 Proteins 0.000 description 4
125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 description 4
108091005804 Peptidases Proteins 0.000 description 4
108010048349 Steroidogenic Factor 1 Proteins 0.000 description 4
230000003213 activating effect Effects 0.000 description 4
239000003242 anti bacterial agent Substances 0.000 description 4
238000003556 assay Methods 0.000 description 4
230000001580 bacterial effect Effects 0.000 description 4
230000027455 binding Effects 0.000 description 4
230000033228 biological regulation Effects 0.000 description 4
230000015572 biosynthetic process Effects 0.000 description 4
238000000576 coating method Methods 0.000 description 4
230000008878 coupling Effects 0.000 description 4
238000010168 coupling process Methods 0.000 description 4
238000005859 coupling reaction Methods 0.000 description 4
230000009260 cross reactivity Effects 0.000 description 4
239000003085 diluting agent Substances 0.000 description 4
239000006185 dispersion Substances 0.000 description 4
238000005516 engineering process Methods 0.000 description 4
239000003623 enhancer Substances 0.000 description 4
210000003527 eukaryotic cell Anatomy 0.000 description 4
210000003958 hematopoietic stem cell Anatomy 0.000 description 4
238000002991 immunohistochemical analysis Methods 0.000 description 4
238000003364 immunohistochemistry Methods 0.000 description 4
150000002632 lipids Chemical class 0.000 description 4
239000007788 liquid Substances 0.000 description 4
230000005923 long-lasting effect Effects 0.000 description 4
239000011859 microparticle Substances 0.000 description 4
229960003966 nicotinamide Drugs 0.000 description 4
235000005152 nicotinamide Nutrition 0.000 description 4
239000011570 nicotinamide Substances 0.000 description 4
230000001019 normoglycemic effect Effects 0.000 description 4
210000004940 nucleus Anatomy 0.000 description 4
239000012188 paraffin wax Substances 0.000 description 4
239000002245 particle Substances 0.000 description 4
150000002978 peroxides Chemical class 0.000 description 4
239000013641 positive control Substances 0.000 description 4
210000001236 prokaryotic cell Anatomy 0.000 description 4
230000001177 retroviral effect Effects 0.000 description 4
238000010839 reverse transcription Methods 0.000 description 4
239000011780 sodium chloride Substances 0.000 description 4
239000002904 solvent Substances 0.000 description 4
208000024891 symptom Diseases 0.000 description 4
238000003786 synthesis reaction Methods 0.000 description 4
238000013518 transcription Methods 0.000 description 4
230000035897 transcription Effects 0.000 description 4
238000002054 transplantation Methods 0.000 description 4
238000001262 western blot Methods 0.000 description 4
239000004382 Amylase Substances 0.000 description 3
102000013142 Amylases Human genes 0.000 description 3
108010065511 Amylases Proteins 0.000 description 3
241000894006 Bacteria Species 0.000 description 3
WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
238000011740 C57BL/6 mouse Methods 0.000 description 3
CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 3
241000701022 Cytomegalovirus Species 0.000 description 3
108090001126 Furin Proteins 0.000 description 3
102000030595 Glucokinase Human genes 0.000 description 3
108010021582 Glucokinase Proteins 0.000 description 3
102000058058 Glucose Transporter Type 2 Human genes 0.000 description 3
239000012981 Hank's balanced salt solution Substances 0.000 description 3
101500028775 Homo sapiens Glucagon Proteins 0.000 description 3
101001053263 Homo sapiens Insulin gene enhancer protein ISL-1 Proteins 0.000 description 3
101001093899 Homo sapiens Retinoic acid receptor RXR-alpha Proteins 0.000 description 3
102100024392 Insulin gene enhancer protein ISL-1 Human genes 0.000 description 3
102000035195 Peptidases Human genes 0.000 description 3
239000004365 Protease Substances 0.000 description 3
238000002123 RNA extraction Methods 0.000 description 3
102100035178 Retinoic acid receptor RXR-alpha Human genes 0.000 description 3
108091006299 SLC2A2 Proteins 0.000 description 3
240000004808 Saccharomyces cerevisiae Species 0.000 description 3
102100035835 Secretogranin-2 Human genes 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
206010067584 Type 1 diabetes mellitus Diseases 0.000 description 3
208000036142 Viral infection Diseases 0.000 description 3
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 3
238000010521 absorption reaction Methods 0.000 description 3
239000011543 agarose gel Substances 0.000 description 3
235000019418 amylase Nutrition 0.000 description 3
239000000427 antigen Substances 0.000 description 3
108091007433 antigens Proteins 0.000 description 3
102000036639 antigens Human genes 0.000 description 3
210000001185 bone marrow Anatomy 0.000 description 3
239000000872 buffer Substances 0.000 description 3
238000004113 cell culture Methods 0.000 description 3
230000001413 cellular effect Effects 0.000 description 3
239000007979 citrate buffer Substances 0.000 description 3
239000011248 coating agent Substances 0.000 description 3
238000013270 controlled release Methods 0.000 description 3
229960004397 cyclophosphamide Drugs 0.000 description 3
230000001419 dependent effect Effects 0.000 description 3
201000010099 disease Diseases 0.000 description 3
239000002612 dispersion medium Substances 0.000 description 3
229940079593 drug Drugs 0.000 description 3
238000004520 electroporation Methods 0.000 description 3
210000001671 embryonic stem cell Anatomy 0.000 description 3
230000002708 enhancing effect Effects 0.000 description 3
238000010195 expression analysis Methods 0.000 description 3
239000012530 fluid Substances 0.000 description 3
102000037865 fusion proteins Human genes 0.000 description 3
108020001507 fusion proteins Proteins 0.000 description 3
239000000499 gel Substances 0.000 description 3
235000011187 glycerol Nutrition 0.000 description 3
230000035876 healing Effects 0.000 description 3
210000003897 hepatic stem cell Anatomy 0.000 description 3
210000005260 human cell Anatomy 0.000 description 3
238000009396 hybridization Methods 0.000 description 3
238000003018 immunoassay Methods 0.000 description 3
238000007914 intraventricular administration Methods 0.000 description 3
230000000670 limiting effect Effects 0.000 description 3
238000005259 measurement Methods 0.000 description 3
239000002609 medium Substances 0.000 description 3
238000010369 molecular cloning Methods 0.000 description 3
229910052757 nitrogen Inorganic materials 0.000 description 3
230000009996 pancreatic endocrine effect Effects 0.000 description 3
239000002504 physiological saline solution Substances 0.000 description 3
239000000843 powder Substances 0.000 description 3
230000035935 pregnancy Effects 0.000 description 3
230000002265 prevention Effects 0.000 description 3
238000000746 purification Methods 0.000 description 3
238000004445 quantitative analysis Methods 0.000 description 3
102000005962 receptors Human genes 0.000 description 3
108020003175 receptors Proteins 0.000 description 3
230000010076 replication Effects 0.000 description 3
235000000346 sugar Nutrition 0.000 description 3
239000000829 suppository Substances 0.000 description 3
239000004094 surface-active agent Substances 0.000 description 3
239000000725 suspension Substances 0.000 description 3
239000003826 tablet Substances 0.000 description 3
238000002560 therapeutic procedure Methods 0.000 description 3
230000000699 topical effect Effects 0.000 description 3
238000010361 transduction Methods 0.000 description 3
230000026683 transduction Effects 0.000 description 3
241000701447 unidentified baculovirus Species 0.000 description 3
239000003981 vehicle Substances 0.000 description 3
230000009385 viral infection Effects 0.000 description 3
102100036475 Alanine aminotransferase 1 Human genes 0.000 description 2
108010082126 Alanine transaminase Proteins 0.000 description 2
102100034044 All-trans-retinol dehydrogenase [NAD(+)] ADH1B Human genes 0.000 description 2
108020005544 Antisense RNA Proteins 0.000 description 2
108010003415 Aspartate Aminotransferases Proteins 0.000 description 2
102000004625 Aspartate Aminotransferases Human genes 0.000 description 2
102100032532 C-type lectin domain family 10 member A Human genes 0.000 description 2
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical group [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
102000000844 Cell Surface Receptors Human genes 0.000 description 2
108010001857 Cell Surface Receptors Proteins 0.000 description 2
108010038447 Chromogranin A Proteins 0.000 description 2
102000010792 Chromogranin A Human genes 0.000 description 2
108010035532 Collagen Proteins 0.000 description 2
102000008186 Collagen Human genes 0.000 description 2
239000003155 DNA primer Substances 0.000 description 2
239000012983 Dulbecco’s minimal essential medium Substances 0.000 description 2
102100031780 Endonuclease Human genes 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
OHCQJHSOBUTRHG-KGGHGJDLSA-N FORSKOLIN Chemical compound O=C([C@@]12O)C[C@](C)(C=C)O[C@]1(C)[C@@H](OC(=O)C)[C@@H](O)[C@@H]1[C@]2(C)[C@@H](O)CCC1(C)C OHCQJHSOBUTRHG-KGGHGJDLSA-N 0.000 description 2
101710198884 GATA-type zinc finger protein 1 Proteins 0.000 description 2
108010010803 Gelatin Proteins 0.000 description 2
DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 description 2
206010018429 Glucose tolerance impaired Diseases 0.000 description 2
102000005720 Glutathione transferase Human genes 0.000 description 2
108010070675 Glutathione transferase Proteins 0.000 description 2
102100029481 Glycogen phosphorylase, liver form Human genes 0.000 description 2
WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
101000942296 Homo sapiens C-type lectin domain family 10 member A Proteins 0.000 description 2
101000700616 Homo sapiens Glycogen phosphorylase, liver form Proteins 0.000 description 2
101000913079 Homo sapiens IgG receptor FcRn large subunit p51 Proteins 0.000 description 2
101000783526 Homo sapiens Neuroendocrine protein 7B2 Proteins 0.000 description 2
101001072231 Homo sapiens Protocadherin-17 Proteins 0.000 description 2
101000632994 Homo sapiens Somatostatin Proteins 0.000 description 2
102100026120 IgG receptor FcRn large subunit p51 Human genes 0.000 description 2
101710186630 Insulin-1 Proteins 0.000 description 2
206010023379 Ketoacidosis Diseases 0.000 description 2
208000007976 Ketosis Diseases 0.000 description 2
241000713666 Lentivirus Species 0.000 description 2
241000124008 Mammalia Species 0.000 description 2
241001529936 Murinae Species 0.000 description 2
101100396998 Mus musculus Ins1 gene Proteins 0.000 description 2
101100072650 Mus musculus Ins2 gene Proteins 0.000 description 2
PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
108091005461 Nucleic proteins Chemical group 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
102100035846 Pigment epithelium-derived factor Human genes 0.000 description 2
102100040918 Pro-glucagon Human genes 0.000 description 2
102100036391 Protocadherin-17 Human genes 0.000 description 2
108010092799 RNA-directed DNA polymerase Proteins 0.000 description 2
102100025003 Ras-related protein R-Ras2 Human genes 0.000 description 2
101100082660 Rattus norvegicus Pdx1 gene Proteins 0.000 description 2
108010002533 Secretogranin II Proteins 0.000 description 2
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
108090001033 Sulfotransferases Proteins 0.000 description 2
102000004896 Sulfotransferases Human genes 0.000 description 2
206010043458 Thirst Diseases 0.000 description 2
102100023543 Vascular cell adhesion protein 1 Human genes 0.000 description 2
206010047513 Vision blurred Diseases 0.000 description 2
239000002253 acid Substances 0.000 description 2
150000007513 acids Chemical class 0.000 description 2
230000009471 action Effects 0.000 description 2
239000013543 active substance Substances 0.000 description 2
FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
229940024606 amino acid Drugs 0.000 description 2
235000001014 amino acid Nutrition 0.000 description 2
150000001413 amino acids Chemical class 0.000 description 2
230000000844 anti-bacterial effect Effects 0.000 description 2
229940121375 antifungal agent Drugs 0.000 description 2
239000003429 antifungal agent Substances 0.000 description 2
238000013459 approach Methods 0.000 description 2
239000007864 aqueous solution Substances 0.000 description 2
235000010323 ascorbic acid Nutrition 0.000 description 2
229960005070 ascorbic acid Drugs 0.000 description 2
239000011668 ascorbic acid Substances 0.000 description 2
230000002238 attenuated effect Effects 0.000 description 2
230000003190 augmentative effect Effects 0.000 description 2
230000008901 benefit Effects 0.000 description 2
230000001588 bifunctional effect Effects 0.000 description 2
239000011230 binding agent Substances 0.000 description 2
210000000601 blood cell Anatomy 0.000 description 2
239000011575 calcium Substances 0.000 description 2
229910052791 calcium Inorganic materials 0.000 description 2
239000001506 calcium phosphate Substances 0.000 description 2
229910000389 calcium phosphate Inorganic materials 0.000 description 2
235000011010 calcium phosphates Nutrition 0.000 description 2
239000006285 cell suspension Substances 0.000 description 2
210000004978 chinese hamster ovary cell Anatomy 0.000 description 2
OSASVXMJTNOKOY-UHFFFAOYSA-N chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 2
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
210000000349 chromosome Anatomy 0.000 description 2
229920001436 collagen Polymers 0.000 description 2
239000003184 complementary RNA Substances 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
230000002950 deficient Effects 0.000 description 2
238000010790 dilution Methods 0.000 description 2
239000012895 dilution Substances 0.000 description 2
238000001493 electron microscopy Methods 0.000 description 2
238000010828 elution Methods 0.000 description 2
229940088598 enzyme Drugs 0.000 description 2
210000002919 epithelial cell Anatomy 0.000 description 2
239000008273 gelatin Substances 0.000 description 2
229920000159 gelatin Polymers 0.000 description 2
235000019322 gelatine Nutrition 0.000 description 2
235000011852 gelatine desserts Nutrition 0.000 description 2
238000007429 general method Methods 0.000 description 2
239000001963 growth medium Substances 0.000 description 2
230000001553 hepatotropic effect Effects 0.000 description 2
230000006801 homologous recombination Effects 0.000 description 2
238000002744 homologous recombination Methods 0.000 description 2
102000045305 human SST Human genes 0.000 description 2
230000002218 hypoglycaemic effect Effects 0.000 description 2
230000002055 immunohistochemical effect Effects 0.000 description 2
238000011532 immunohistochemical staining Methods 0.000 description 2
239000007943 implant Substances 0.000 description 2
238000001802 infusion Methods 0.000 description 2
239000003112 inhibitor Substances 0.000 description 2
206010022498 insulinoma Diseases 0.000 description 2
238000010253 intravenous injection Methods 0.000 description 2
238000002642 intravenous therapy Methods 0.000 description 2
238000002955 isolation Methods 0.000 description 2
239000007951 isotonicity adjuster Substances 0.000 description 2
239000003446 ligand Substances 0.000 description 2
238000001638 lipofection Methods 0.000 description 2
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
239000012528 membrane Substances 0.000 description 2
210000004379 membrane Anatomy 0.000 description 2
OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 2
238000002493 microarray Methods 0.000 description 2
244000005700 microbiome Species 0.000 description 2
239000003094 microcapsule Substances 0.000 description 2
230000027939 micturition Effects 0.000 description 2
230000004048 modification Effects 0.000 description 2
238000012986 modification Methods 0.000 description 2
210000003205 muscle Anatomy 0.000 description 2
210000004457 myocytus nodalis Anatomy 0.000 description 2
239000006199 nebulizer Substances 0.000 description 2
230000001537 neural effect Effects 0.000 description 2
230000000955 neuroendocrine Effects 0.000 description 2
210000004412 neuroendocrine cell Anatomy 0.000 description 2
239000000346 nonvolatile oil Substances 0.000 description 2
239000002674 ointment Substances 0.000 description 2
230000005305 organ development Effects 0.000 description 2
210000004923 pancreatic tissue Anatomy 0.000 description 2
230000002085 persistent effect Effects 0.000 description 2
239000000546 pharmaceutical excipient Substances 0.000 description 2
239000000825 pharmaceutical preparation Substances 0.000 description 2
239000004033 plastic Substances 0.000 description 2
229920003023 plastic Polymers 0.000 description 2
229920001223 polyethylene glycol Polymers 0.000 description 2
230000002035 prolonged effect Effects 0.000 description 2
230000001737 promoting effect Effects 0.000 description 2
235000019419 proteases Nutrition 0.000 description 2
230000010837 receptor-mediated endocytosis Effects 0.000 description 2
238000004007 reversed phase HPLC Methods 0.000 description 2
230000002441 reversible effect Effects 0.000 description 2
230000003068 static effect Effects 0.000 description 2
238000003756 stirring Methods 0.000 description 2
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
239000006228 supernatant Substances 0.000 description 2
238000001356 surgical procedure Methods 0.000 description 2
230000009466 transformation Effects 0.000 description 2
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
210000002845 virion Anatomy 0.000 description 2
210000005253 yeast cell Anatomy 0.000 description 2
ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
ULSWSROTDLVALI-YJEPMDBQSA-N (4R,7S,10S,13S,16S,19S,22S,25S,28S,31S,34S,37R)-37-[[2-[[(2S)-2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-4-amino-2-[[(2S)-2-amino-3-hydroxypropanoyl]amino]-4-oxobutanoyl]pyrrolidine-2-carbonyl]amino]propanoyl]amino]-4-methylsulfanylbutanoyl]amino]propanoyl]pyrrolidine-2-carbonyl]amino]-5-carbamimidamidopentanoyl]amino]-4-carboxybutanoyl]amino]-5-carbamimidamidopentanoyl]amino]hexanoyl]amino]propanoyl]amino]acetyl]amino]-19,34-bis(4-aminobutyl)-31-(2-amino-2-oxoethyl)-13,25,28-tribenzyl-10,16-bis[(1R)-1-hydroxyethyl]-7-(hydroxymethyl)-22-(1H-indol-3-ylmethyl)-6,9,12,15,18,21,24,27,30,33,36-undecaoxo-1,2-dithia-5,8,11,14,17,20,23,26,29,32,35-undecazacyclooctatriacontane-4-carboxylic acid Chemical compound N([C@@H](C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]1C(N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CSSC1)C(O)=O)[C@@H](C)O)[C@@H](C)O)=O)C(=O)[C@@H]1CCCN1C(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO ULSWSROTDLVALI-YJEPMDBQSA-N 0.000 description 1
IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
101150072531 10 gene Proteins 0.000 description 1
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
101150098072 20 gene Proteins 0.000 description 1
108020005029 5' Flanking Region Proteins 0.000 description 1
HFDKKNHCYWNNNQ-YOGANYHLSA-N 75976-10-2 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@@H](NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](C)N)C(C)C)[C@@H](C)O)C1=CC=C(O)C=C1 HFDKKNHCYWNNNQ-YOGANYHLSA-N 0.000 description 1
102000007469 Actins Human genes 0.000 description 1
108010085238 Actins Proteins 0.000 description 1
229920000936 Agarose Polymers 0.000 description 1
101710095142 Alcohol dehydrogenase 1B Proteins 0.000 description 1
102100024090 Aldo-keto reductase family 1 member C3 Human genes 0.000 description 1
101710108164 All-trans-retinol dehydrogenase [NAD(+)] ADH1B Proteins 0.000 description 1
102100023635 Alpha-fetoprotein Human genes 0.000 description 1
101710083889 Alpha-fetoprotein Proteins 0.000 description 1
102100026882 Alpha-synuclein Human genes 0.000 description 1
APKFDSVGJQXUKY-KKGHZKTASA-N Amphotericin-B Natural products O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-KKGHZKTASA-N 0.000 description 1
102000018757 Apolipoprotein L1 Human genes 0.000 description 1
102100030762 Apolipoprotein L1 Human genes 0.000 description 1
108010052469 Apolipoprotein L1 Proteins 0.000 description 1
241000416162 Astragalus gummifer Species 0.000 description 1
241000271566 Aves Species 0.000 description 1
210000002237 B-cell of pancreatic islet Anatomy 0.000 description 1
238000011725 BALB/c mouse Methods 0.000 description 1
GWZYPXHJIZCRAJ-UHFFFAOYSA-N Biliverdin Natural products CC1=C(C=C)C(=C/C2=NC(=Cc3[nH]c(C=C/4NC(=O)C(=C4C)C=C)c(C)c3CCC(=O)O)C(=C2C)CCC(=O)O)NC1=O GWZYPXHJIZCRAJ-UHFFFAOYSA-N 0.000 description 1
RCNSAJSGRJSBKK-NSQVQWHSSA-N Biliverdin IX Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(\C=C/2C(=C(C)C(=C/C=3C(=C(C=C)C(=O)N=3)C)/N\2)CCC(O)=O)N1 RCNSAJSGRJSBKK-NSQVQWHSSA-N 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
102100029303 Calcium-regulated heat-stable protein 1 Human genes 0.000 description 1
240000001432 Calendula officinalis Species 0.000 description 1
235000005881 Calendula officinalis Nutrition 0.000 description 1
102000014914 Carrier Proteins Human genes 0.000 description 1
102100035882 Catalase Human genes 0.000 description 1
108010053835 Catalase Proteins 0.000 description 1
102100035294 Chemokine XC receptor 1 Human genes 0.000 description 1
108010077544 Chromatin Proteins 0.000 description 1
102100031186 Chromogranin-A Human genes 0.000 description 1
102100026099 Claudin domain-containing protein 1 Human genes 0.000 description 1
101000856234 Clostridium acetobutylicum (strain ATCC 824 / DSM 792 / JCM 1419 / LMG 5710 / VKM B-1787) Butyrate-acetoacetate CoA-transferase subunit A Proteins 0.000 description 1
108091026890 Coding region Proteins 0.000 description 1
108020004705 Codon Proteins 0.000 description 1
102000029816 Collagenase Human genes 0.000 description 1
108060005980 Collagenase Proteins 0.000 description 1
102100030149 Complement C1r subcomponent Human genes 0.000 description 1
229920002261 Corn starch Polymers 0.000 description 1
108010070357 D-Aspartate Oxidase Proteins 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
102000005680 D-aspartate oxidase Human genes 0.000 description 1
CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
102000004594 DNA Polymerase I Human genes 0.000 description 1
108010017826 DNA Polymerase I Proteins 0.000 description 1
230000004544 DNA amplification Effects 0.000 description 1
230000007067 DNA methylation Effects 0.000 description 1
230000006820 DNA synthesis Effects 0.000 description 1
230000004568 DNA-binding Effects 0.000 description 1
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
241000252212 Danio rerio Species 0.000 description 1
SUZLHDUTVMZSEV-UHFFFAOYSA-N Deoxycoleonol Natural products C12C(=O)CC(C)(C=C)OC2(C)C(OC(=O)C)C(O)C2C1(C)C(O)CCC2(C)C SUZLHDUTVMZSEV-UHFFFAOYSA-N 0.000 description 1
102000007260 Deoxyribonuclease I Human genes 0.000 description 1
108010008532 Deoxyribonuclease I Proteins 0.000 description 1
241000702421 Dependoparvovirus Species 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
102000017930 EDNRB Human genes 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
238000002965 ELISA Methods 0.000 description 1
238000008157 ELISA kit Methods 0.000 description 1
101150084967 EPCAM gene Proteins 0.000 description 1
102000005593 Endopeptidases Human genes 0.000 description 1
108010059378 Endopeptidases Proteins 0.000 description 1
241000792859 Enema Species 0.000 description 1
108010013369 Enteropeptidase Proteins 0.000 description 1
102100029727 Enteropeptidase Human genes 0.000 description 1
YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 1
102100031940 Epithelial cell adhesion molecule Human genes 0.000 description 1
241000283073 Equus caballus Species 0.000 description 1
108700024394 Exon Proteins 0.000 description 1
108010074860 Factor Xa Proteins 0.000 description 1
241000282326 Felis catus Species 0.000 description 1
102000016359 Fibronectins Human genes 0.000 description 1
108010067306 Fibronectins Proteins 0.000 description 1
102100027944 Flavin reductase (NADPH) Human genes 0.000 description 1
238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 1
108010014612 Follistatin Proteins 0.000 description 1
102000016970 Follistatin Human genes 0.000 description 1
102100020921 Follistatin Human genes 0.000 description 1
241000233866 Fungi Species 0.000 description 1
102000004961 Furin Human genes 0.000 description 1
101150066002 GFP gene Proteins 0.000 description 1
102100028652 Gamma-enolase Human genes 0.000 description 1
102000003638 Glucose-6-Phosphatase Human genes 0.000 description 1
108010086800 Glucose-6-Phosphatase Proteins 0.000 description 1
SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
229920002527 Glycogen Polymers 0.000 description 1
108010051696 Growth Hormone Proteins 0.000 description 1
241000288105 Grus Species 0.000 description 1
102100029283 Hepatocyte nuclear factor 3-alpha Human genes 0.000 description 1
102100029284 Hepatocyte nuclear factor 3-beta Human genes 0.000 description 1
102100034826 Homeobox protein Meis2 Human genes 0.000 description 1
102100027886 Homeobox protein Nkx-2.2 Human genes 0.000 description 1
108010048671 Homeodomain Proteins Proteins 0.000 description 1
102000009331 Homeodomain Proteins Human genes 0.000 description 1
101100323521 Homo sapiens APOL1 gene Proteins 0.000 description 1
101000834898 Homo sapiens Alpha-synuclein Proteins 0.000 description 1
101000989513 Homo sapiens Calcium-regulated heat-stable protein 1 Proteins 0.000 description 1
101000804783 Homo sapiens Chemokine XC receptor 1 Proteins 0.000 description 1
101000993094 Homo sapiens Chromogranin-A Proteins 0.000 description 1
101000912657 Homo sapiens Claudin domain-containing protein 1 Proteins 0.000 description 1
101000794279 Homo sapiens Complement C1r subcomponent Proteins 0.000 description 1
101000967299 Homo sapiens Endothelin receptor type B Proteins 0.000 description 1
101000935587 Homo sapiens Flavin reductase (NADPH) Proteins 0.000 description 1
101001058231 Homo sapiens Gamma-enolase Proteins 0.000 description 1
101001062353 Homo sapiens Hepatocyte nuclear factor 3-alpha Proteins 0.000 description 1
101001062347 Homo sapiens Hepatocyte nuclear factor 3-beta Proteins 0.000 description 1
101000840558 Homo sapiens Hexokinase-4 Proteins 0.000 description 1
101001019057 Homo sapiens Homeobox protein Meis2 Proteins 0.000 description 1
101000632186 Homo sapiens Homeobox protein Nkx-2.2 Proteins 0.000 description 1
101100519290 Homo sapiens PDX1 gene Proteins 0.000 description 1
101000595918 Homo sapiens Phospholipase A and acyltransferase 4 Proteins 0.000 description 1
101000610110 Homo sapiens Pre-B-cell leukemia transcription factor 2 Proteins 0.000 description 1
101001122995 Homo sapiens Protein phosphatase 1 regulatory subunit 3C Proteins 0.000 description 1
101000795018 Homo sapiens Putative trypsin-6 Proteins 0.000 description 1
101000686227 Homo sapiens Ras-related protein R-Ras2 Proteins 0.000 description 1
101001106672 Homo sapiens Regulator of G-protein signaling 2 Proteins 0.000 description 1
101001096522 Homo sapiens Regulator of G-protein signaling 5 Proteins 0.000 description 1
101000927796 Homo sapiens Rho guanine nucleotide exchange factor 7 Proteins 0.000 description 1
101000654764 Homo sapiens Secretagogin Proteins 0.000 description 1
101000655897 Homo sapiens Serine protease 1 Proteins 0.000 description 1
101000987315 Homo sapiens Serine/threonine-protein kinase PAK 3 Proteins 0.000 description 1
101000826399 Homo sapiens Sulfotransferase 1A1 Proteins 0.000 description 1
101000826390 Homo sapiens Sulfotransferase 1A3 Proteins 0.000 description 1
101000759892 Homo sapiens Tetraspanin-13 Proteins 0.000 description 1
101000633617 Homo sapiens Thrombospondin-4 Proteins 0.000 description 1
101000819074 Homo sapiens Transcription factor GATA-4 Proteins 0.000 description 1
101000819088 Homo sapiens Transcription factor GATA-6 Proteins 0.000 description 1
101001074042 Homo sapiens Transcriptional activator GLI3 Proteins 0.000 description 1
101000622304 Homo sapiens Vascular cell adhesion protein 1 Proteins 0.000 description 1
101001032478 Homo sapiens cAMP-dependent protein kinase inhibitor alpha Proteins 0.000 description 1
101001026578 Hordeum vulgare Ent-kaurenoic acid oxidase 1 Proteins 0.000 description 1
102000008100 Human Serum Albumin Human genes 0.000 description 1
108091006905 Human Serum Albumin Proteins 0.000 description 1
241000701109 Human adenovirus 2 Species 0.000 description 1
241000328826 Human adenovirus 52 Species 0.000 description 1
208000013016 Hypoglycemia Diseases 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
108060003951 Immunoglobulin Proteins 0.000 description 1
206010062016 Immunosuppression Diseases 0.000 description 1
102100027004 Inhibin beta A chain Human genes 0.000 description 1
102100023915 Insulin Human genes 0.000 description 1
102000005755 Intercellular Signaling Peptides and Proteins Human genes 0.000 description 1
108010070716 Intercellular Signaling Peptides and Proteins Proteins 0.000 description 1
108090001005 Interleukin-6 Proteins 0.000 description 1
206010022998 Irritability Diseases 0.000 description 1
101710172072 Kexin Proteins 0.000 description 1
101710177504 Kit ligand Proteins 0.000 description 1
WQZGKKKJIJFFOK-ZZWDRFIYSA-N L-glucose Chemical compound OC[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@H]1O WQZGKKKJIJFFOK-ZZWDRFIYSA-N 0.000 description 1
FBOZXECLQNJBKD-ZDUSSCGKSA-N L-methotrexate Chemical compound C=1N=C2N=C(N)N=C(N)C2=NC=1CN(C)C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 FBOZXECLQNJBKD-ZDUSSCGKSA-N 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 1
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
244000246386 Mentha pulegium Species 0.000 description 1
235000016257 Mentha pulegium Nutrition 0.000 description 1
235000004357 Mentha x piperita Nutrition 0.000 description 1
101150036570 Mi-2 gene Proteins 0.000 description 1
229920000168 Microcrystalline cellulose Polymers 0.000 description 1
101000985214 Mus musculus 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 description 1
101001128692 Mus musculus Neuroendocrine convertase 1 Proteins 0.000 description 1
108010021466 Mutant Proteins Proteins 0.000 description 1
102000008300 Mutant Proteins Human genes 0.000 description 1
108091061960 Naked DNA Proteins 0.000 description 1
206010028813 Nausea Diseases 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
102100036248 Neuroendocrine protein 7B2 Human genes 0.000 description 1
108010088373 Neurofilament Proteins Proteins 0.000 description 1
102000008763 Neurofilament Proteins Human genes 0.000 description 1
238000000636 Northern blotting Methods 0.000 description 1
108010077850 Nuclear Localization Signals Proteins 0.000 description 1
108010084438 Oncogene Protein v-maf Proteins 0.000 description 1
108700026244 Open Reading Frames Proteins 0.000 description 1
102000007354 PAX6 Transcription Factor Human genes 0.000 description 1
108010032788 PAX6 Transcription Factor Proteins 0.000 description 1
101150081664 PAX6 gene Proteins 0.000 description 1
238000010222 PCR analysis Methods 0.000 description 1
238000002944 PCR assay Methods 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
102100037506 Paired box protein Pax-6 Human genes 0.000 description 1
102000018886 Pancreatic Polypeptide Human genes 0.000 description 1
108010074467 Pancreatitis-Associated Proteins Proteins 0.000 description 1
102000008080 Pancreatitis-Associated Proteins Human genes 0.000 description 1
101150075928 Pax4 gene Proteins 0.000 description 1
229930182555 Penicillin Natural products 0.000 description 1
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
102000003992 Peroxidases Human genes 0.000 description 1
241000009328 Perro Species 0.000 description 1
102100028251 Phosphoglycerate kinase 1 Human genes 0.000 description 1
101710139464 Phosphoglycerate kinase 1 Proteins 0.000 description 1
102100035200 Phospholipase A and acyltransferase 4 Human genes 0.000 description 1
108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 1
102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 1
108091000080 Phosphotransferase Proteins 0.000 description 1
229920002732 Polyanhydride Polymers 0.000 description 1
239000002202 Polyethylene glycol Substances 0.000 description 1
229920000954 Polyglycolide Polymers 0.000 description 1
229920001710 Polyorthoester Polymers 0.000 description 1
108010005991 Pork Regular Insulin Proteins 0.000 description 1
102100040168 Pre-B-cell leukemia transcription factor 2 Human genes 0.000 description 1
102100040169 Pre-B-cell leukemia transcription factor 3 Human genes 0.000 description 1
102000007584 Prealbumin Human genes 0.000 description 1
108010071690 Prealbumin Proteins 0.000 description 1
108090000545 Proprotein Convertase 2 Proteins 0.000 description 1
102000004088 Proprotein Convertase 2 Human genes 0.000 description 1
102000006437 Proprotein Convertases Human genes 0.000 description 1
108010044159 Proprotein Convertases Proteins 0.000 description 1
GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical class CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
108010065942 Prostaglandin-F synthase Proteins 0.000 description 1
101710180316 Protease 2 Proteins 0.000 description 1
102100028506 Protein phosphatase 1 regulatory subunit 3C Human genes 0.000 description 1
102100037860 Psychosine receptor Human genes 0.000 description 1
101710204091 Psychosine receptor Proteins 0.000 description 1
102100029629 Putative trypsin-6 Human genes 0.000 description 1
101710183548 Pyridoxal 5'-phosphate synthase subunit PdxS Proteins 0.000 description 1
238000011529 RT qPCR Methods 0.000 description 1
101710154822 Ras-related protein R-Ras2 Proteins 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
102100021258 Regulator of G-protein signaling 2 Human genes 0.000 description 1
102100037421 Regulator of G-protein signaling 5 Human genes 0.000 description 1
108700008625 Reporter Genes Proteins 0.000 description 1
102100038053 Retinol dehydrogenase 5 Human genes 0.000 description 1
101150029512 SCG2 gene Proteins 0.000 description 1
238000011579 SCID mouse model Methods 0.000 description 1
102100032621 Secretagogin Human genes 0.000 description 1
108050000810 Secretogranin-2 Proteins 0.000 description 1
102100032491 Serine protease 1 Human genes 0.000 description 1
102100027911 Serine/threonine-protein kinase PAK 3 Human genes 0.000 description 1
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
102100038803 Somatotropin Human genes 0.000 description 1
229920002472 Starch Polymers 0.000 description 1
108010090804 Streptavidin Proteins 0.000 description 1
ZSJLQEPLLKMAKR-UHFFFAOYSA-N Streptozotocin Natural products O=NN(C)C(=O)NC1C(O)OC(CO)C(O)C1O ZSJLQEPLLKMAKR-UHFFFAOYSA-N 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
102100023986 Sulfotransferase 1A1 Human genes 0.000 description 1
102100023983 Sulfotransferase 1A3 Human genes 0.000 description 1
101000983124 Sus scrofa Pancreatic prohormone precursor Proteins 0.000 description 1
108091008874 T cell receptors Proteins 0.000 description 1
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
101150057140 TACSTD1 gene Proteins 0.000 description 1
239000004809 Teflon Substances 0.000 description 1
229920006362 Teflon® Polymers 0.000 description 1
102100024996 Tetraspanin-13 Human genes 0.000 description 1
241000473945 Theria <moth genus> Species 0.000 description 1
108090000190 Thrombin Proteins 0.000 description 1
102100029219 Thrombospondin-4 Human genes 0.000 description 1
108010034949 Thyroglobulin Proteins 0.000 description 1
102000009843 Thyroglobulin Human genes 0.000 description 1
101710113649 Thyroid peroxidase Proteins 0.000 description 1
238000008050 Total Bilirubin Reagent Methods 0.000 description 1
229920001615 Tragacanth Polymers 0.000 description 1
102100021380 Transcription factor GATA-4 Human genes 0.000 description 1
102100021382 Transcription factor GATA-6 Human genes 0.000 description 1
108050004365 Transcription factor Maf Proteins 0.000 description 1
102100039189 Transcription factor Maf Human genes 0.000 description 1
102100035559 Transcriptional activator GLI3 Human genes 0.000 description 1
COQLPRJCUIATTQ-UHFFFAOYSA-N Uranyl acetate Chemical compound O.O.O=[U]=O.CC(O)=O.CC(O)=O COQLPRJCUIATTQ-UHFFFAOYSA-N 0.000 description 1
108010000134 Vascular Cell Adhesion Molecule-1 Proteins 0.000 description 1
108020005202 Viral DNA Proteins 0.000 description 1
239000005862 Whey Substances 0.000 description 1
102000007544 Whey Proteins Human genes 0.000 description 1
108010046377 Whey Proteins Proteins 0.000 description 1
206010052428 Wound Diseases 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
108010088665 Zinc Finger Protein Gli2 Proteins 0.000 description 1
102100035558 Zinc finger protein GLI2 Human genes 0.000 description 1
OGQICQVSFDPSEI-UHFFFAOYSA-N Zorac Chemical compound N1=CC(C(=O)OCC)=CC=C1C#CC1=CC=C(SCCC2(C)C)C2=C1 OGQICQVSFDPSEI-UHFFFAOYSA-N 0.000 description 1
206010000210 abortion Diseases 0.000 description 1
231100000176 abortion Toxicity 0.000 description 1
239000003070 absorption delaying agent Substances 0.000 description 1
150000001242 acetic acid derivatives Chemical class 0.000 description 1
230000001464 adherent effect Effects 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
239000000443 aerosol Substances 0.000 description 1
238000001261 affinity purification Methods 0.000 description 1
238000000246 agarose gel electrophoresis Methods 0.000 description 1
239000000783 alginic acid Substances 0.000 description 1
235000010443 alginic acid Nutrition 0.000 description 1
229920000615 alginic acid Polymers 0.000 description 1
229960001126 alginic acid Drugs 0.000 description 1
150000004781 alginic acids Chemical class 0.000 description 1
SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 1
108090000183 alpha-2-Antiplasmin Proteins 0.000 description 1
APKFDSVGJQXUKY-INPOYWNPSA-N amphotericin B Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C=C/C=C/C=C/[C@H](C)[C@@H](O)[C@@H](C)[C@H](C)OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 APKFDSVGJQXUKY-INPOYWNPSA-N 0.000 description 1
229960003942 amphotericin b Drugs 0.000 description 1
238000010171 animal model Methods 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
239000003963 antioxidant agent Substances 0.000 description 1
235000006708 antioxidants Nutrition 0.000 description 1
238000003491 array Methods 0.000 description 1
239000012131 assay buffer Substances 0.000 description 1
239000012298 atmosphere Substances 0.000 description 1
230000001363 autoimmune Effects 0.000 description 1
230000006470 autoimmune attack Effects 0.000 description 1
239000013602 bacteriophage vector Substances 0.000 description 1
230000003385 bacteriostatic effect Effects 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
235000019445 benzyl alcohol Nutrition 0.000 description 1
239000003613 bile acid Substances 0.000 description 1
239000003833 bile salt Substances 0.000 description 1
229940093761 bile salts Drugs 0.000 description 1
QBUVFDKTZJNUPP-UHFFFAOYSA-N biliverdin-IXalpha Natural products N1C(=O)C(C)=C(C=C)C1=CC1=C(C)C(CCC(O)=O)=C(C=C2C(=C(C)C(C=C3C(=C(C=C)C(=O)N3)C)=N2)CCC(O)=O)N1 QBUVFDKTZJNUPP-UHFFFAOYSA-N 0.000 description 1
108091008324 binding proteins Proteins 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
229920000249 biocompatible polymer Polymers 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
238000001574 biopsy Methods 0.000 description 1
HOQPTLCRWVZIQZ-UHFFFAOYSA-H bis[[2-(5-hydroxy-4,7-dioxo-1,3,2$l^{2}-dioxaplumbepan-5-yl)acetyl]oxy]lead Chemical compound [Pb+2].[Pb+2].[Pb+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HOQPTLCRWVZIQZ-UHFFFAOYSA-H 0.000 description 1
230000036772 blood pressure Effects 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 description 1
102100038086 cAMP-dependent protein kinase inhibitor alpha Human genes 0.000 description 1
239000001110 calcium chloride Substances 0.000 description 1
229910001628 calcium chloride Inorganic materials 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
239000001569 carbon dioxide Substances 0.000 description 1
229910002092 carbon dioxide Inorganic materials 0.000 description 1
229910002091 carbon monoxide Inorganic materials 0.000 description 1
210000004413 cardiac myocyte Anatomy 0.000 description 1
230000003915 cell function Effects 0.000 description 1
230000007910 cell fusion Effects 0.000 description 1
238000011072 cell harvest Methods 0.000 description 1
230000004663 cell proliferation Effects 0.000 description 1
230000003833 cell viability Effects 0.000 description 1
210000003169 central nervous system Anatomy 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
230000008859 change Effects 0.000 description 1
239000002738 chelating agent Substances 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
229960004926 chlorobutanol Drugs 0.000 description 1
235000012000 cholesterol Nutrition 0.000 description 1
210000003483 chromatin Anatomy 0.000 description 1
150000001860 citric acid derivatives Chemical class 0.000 description 1
238000000975 co-precipitation Methods 0.000 description 1
229940110456 cocoa butter Drugs 0.000 description 1
235000019868 cocoa butter Nutrition 0.000 description 1
OHCQJHSOBUTRHG-UHFFFAOYSA-N colforsin Natural products OC12C(=O)CC(C)(C=C)OC1(C)C(OC(=O)C)C(O)C1C2(C)C(O)CCC1(C)C OHCQJHSOBUTRHG-UHFFFAOYSA-N 0.000 description 1
229960002424 collagenase Drugs 0.000 description 1
229940075614 colloidal silicon dioxide Drugs 0.000 description 1
230000003918 constitutive secretory pathway Effects 0.000 description 1
238000010276 construction Methods 0.000 description 1
238000011109 contamination Methods 0.000 description 1
230000001276 controlling effect Effects 0.000 description 1
239000008120 corn starch Substances 0.000 description 1
239000006071 cream Substances 0.000 description 1
238000012258 culturing Methods 0.000 description 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
235000018417 cysteine Nutrition 0.000 description 1
230000001086 cytosolic effect Effects 0.000 description 1
230000032459 dedifferentiation Effects 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
230000001934 delay Effects 0.000 description 1
238000012217 deletion Methods 0.000 description 1
230000037430 deletion Effects 0.000 description 1
238000013461 design Methods 0.000 description 1
239000003599 detergent Substances 0.000 description 1
238000011161 development Methods 0.000 description 1
230000018109 developmental process Effects 0.000 description 1
239000008121 dextrose Substances 0.000 description 1
238000002405 diagnostic procedure Methods 0.000 description 1
235000005911 diet Nutrition 0.000 description 1
230000037213 diet Effects 0.000 description 1
UGMCXQCYOVCMTB-UHFFFAOYSA-K dihydroxy(stearato)aluminium Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[Al](O)O UGMCXQCYOVCMTB-UHFFFAOYSA-K 0.000 description 1
230000000667 effect on insulin Effects 0.000 description 1
238000010218 electron microscopic analysis Methods 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
210000002257 embryonic structure Anatomy 0.000 description 1
238000005538 encapsulation Methods 0.000 description 1
229940066758 endopeptidases Drugs 0.000 description 1
230000003511 endothelial effect Effects 0.000 description 1
239000007920 enema Substances 0.000 description 1
229940079360 enema for constipation Drugs 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
210000002615 epidermis Anatomy 0.000 description 1
210000000981 epithelium Anatomy 0.000 description 1
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
229960005542 ethidium bromide Drugs 0.000 description 1
DEFVIWRASFVYLL-UHFFFAOYSA-N ethylene glycol bis(2-aminoethyl)tetraacetic acid Chemical compound OC(=O)CN(CC(O)=O)CCOCCOCCN(CC(O)=O)CC(O)=O DEFVIWRASFVYLL-UHFFFAOYSA-N 0.000 description 1
239000005038 ethylene vinyl acetate Substances 0.000 description 1
210000003020 exocrine pancreas Anatomy 0.000 description 1
235000019197 fats Nutrition 0.000 description 1
210000004700 fetal blood Anatomy 0.000 description 1
210000003754 fetus Anatomy 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
239000000796 flavoring agent Substances 0.000 description 1
108700014844 flt3 ligand Proteins 0.000 description 1
235000013355 food flavoring agent Nutrition 0.000 description 1
235000003599 food sweetener Nutrition 0.000 description 1
IECPWNUMDGFDKC-MZJAQBGESA-N fusidic acid Chemical class O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C(O)=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C IECPWNUMDGFDKC-MZJAQBGESA-N 0.000 description 1
239000007789 gas Substances 0.000 description 1
239000007903 gelatin capsule Substances 0.000 description 1
102000034356 gene-regulatory proteins Human genes 0.000 description 1
108091006104 gene-regulatory proteins Proteins 0.000 description 1
238000012252 genetic analysis Methods 0.000 description 1
239000011521 glass Substances 0.000 description 1
150000002303 glucose derivatives Chemical class 0.000 description 1
230000009229 glucose formation Effects 0.000 description 1
238000007446 glucose tolerance test Methods 0.000 description 1
125000005456 glyceride group Chemical group 0.000 description 1
229940096919 glycogen Drugs 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
229910052737 gold Inorganic materials 0.000 description 1
239000010931 gold Substances 0.000 description 1
239000008187 granular material Substances 0.000 description 1
230000012010 growth Effects 0.000 description 1
239000000122 growth hormone Substances 0.000 description 1
230000003394 haemopoietic effect Effects 0.000 description 1
238000003306 harvesting Methods 0.000 description 1
230000036541 health Effects 0.000 description 1
208000006454 hepatitis Diseases 0.000 description 1
231100000283 hepatitis Toxicity 0.000 description 1
230000003054 hormonal effect Effects 0.000 description 1
235000001050 hortel pimenta Nutrition 0.000 description 1
102000057198 human SCG2 Human genes 0.000 description 1
102000045342 human SCG5 Human genes 0.000 description 1
235000003642 hunger Nutrition 0.000 description 1
238000003365 immunocytochemistry Methods 0.000 description 1
102000018358 immunoglobulin Human genes 0.000 description 1
229940072221 immunoglobulins Drugs 0.000 description 1
238000012744 immunostaining Methods 0.000 description 1
230000001506 immunosuppresive effect Effects 0.000 description 1
230000001771 impaired effect Effects 0.000 description 1
238000000099 in vitro assay Methods 0.000 description 1
238000010874 in vitro model Methods 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
238000011221 initial treatment Methods 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
239000013546 insoluble monolayer Substances 0.000 description 1
238000012528 insulin ELISA Methods 0.000 description 1
230000010354 integration Effects 0.000 description 1
210000004347 intestinal mucosa Anatomy 0.000 description 1
230000031146 intracellular signal transduction Effects 0.000 description 1
238000007918 intramuscular administration Methods 0.000 description 1
239000007928 intraperitoneal injection Substances 0.000 description 1
238000007913 intrathecal administration Methods 0.000 description 1
238000011835 investigation Methods 0.000 description 1
230000002427 irreversible effect Effects 0.000 description 1
239000008101 lactose Substances 0.000 description 1
239000010410 layer Substances 0.000 description 1
239000000787 lecithin Substances 0.000 description 1
235000010445 lecithin Nutrition 0.000 description 1
229940067606 lecithin Drugs 0.000 description 1
239000004973 liquid crystal related substance Substances 0.000 description 1
230000007774 longterm Effects 0.000 description 1
239000000314 lubricant Substances 0.000 description 1
235000019359 magnesium stearate Nutrition 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
210000005075 mammary gland Anatomy 0.000 description 1
108010082117 matrigel Proteins 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
230000007246 mechanism Effects 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
230000004060 metabolic process Effects 0.000 description 1
MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
229960000485 methotrexate Drugs 0.000 description 1
STZCRXQWRGQSJD-GEEYTBSJSA-M methyl orange Chemical compound [Na+].C1=CC(N(C)C)=CC=C1\N=N\C1=CC=C(S([O-])(=O)=O)C=C1 STZCRXQWRGQSJD-GEEYTBSJSA-M 0.000 description 1
229940012189 methyl orange Drugs 0.000 description 1
235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
229960001047 methyl salicylate Drugs 0.000 description 1
239000000693 micelle Substances 0.000 description 1
235000019813 microcrystalline cellulose Nutrition 0.000 description 1
239000008108 microcrystalline cellulose Substances 0.000 description 1
229940016286 microcrystalline cellulose Drugs 0.000 description 1
238000000520 microinjection Methods 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
239000008267 milk Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
230000003278 mimic effect Effects 0.000 description 1
239000003147 molecular marker Substances 0.000 description 1
238000004264 monolayer culture Methods 0.000 description 1
238000010172 mouse model Methods 0.000 description 1
210000002200 mouth mucosa Anatomy 0.000 description 1
239000002324 mouth wash Substances 0.000 description 1
229940051866 mouthwash Drugs 0.000 description 1
210000000663 muscle cell Anatomy 0.000 description 1
230000035772 mutation Effects 0.000 description 1
239000007922 nasal spray Substances 0.000 description 1
239000006218 nasal suppository Substances 0.000 description 1
230000008693 nausea Effects 0.000 description 1
239000013642 negative control Substances 0.000 description 1
210000001178 neural stem cell Anatomy 0.000 description 1
210000005044 neurofilament Anatomy 0.000 description 1
210000002569 neuron Anatomy 0.000 description 1
229910052759 nickel Inorganic materials 0.000 description 1
239000002687 nonaqueous vehicle Substances 0.000 description 1
235000021062 nutrient metabolism Nutrition 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
230000004203 pancreatic function Effects 0.000 description 1
208000021255 pancreatic insulinoma Diseases 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
239000008188 pellet Substances 0.000 description 1
229940049954 penicillin Drugs 0.000 description 1
239000000813 peptide hormone Substances 0.000 description 1
239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
210000005259 peripheral blood Anatomy 0.000 description 1
239000011886 peripheral blood Substances 0.000 description 1
108040007629 peroxidase activity proteins Proteins 0.000 description 1
229960003742 phenol Drugs 0.000 description 1
235000021317 phosphate Nutrition 0.000 description 1
150000003904 phospholipids Chemical class 0.000 description 1
150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
102000020233 phosphotransferase Human genes 0.000 description 1
230000035790 physiological processes and functions Effects 0.000 description 1
108090000102 pigment epithelium-derived factor Proteins 0.000 description 1
239000006187 pill Substances 0.000 description 1
238000007747 plating Methods 0.000 description 1
210000001778 pluripotent stem cell Anatomy 0.000 description 1
229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
229920000747 poly(lactic acid) Polymers 0.000 description 1
229920002401 polyacrylamide Polymers 0.000 description 1
230000008488 polyadenylation Effects 0.000 description 1
239000008389 polyethoxylated castor oil Substances 0.000 description 1
239000004633 polyglycolic acid Substances 0.000 description 1
239000004626 polylactic acid Substances 0.000 description 1
238000003752 polymerase chain reaction Methods 0.000 description 1
229920005862 polyol Polymers 0.000 description 1
150000003077 polyols Chemical class 0.000 description 1
210000003240 portal vein Anatomy 0.000 description 1
230000003389 potentiating effect Effects 0.000 description 1
230000002028 premature Effects 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
230000035755 proliferation Effects 0.000 description 1
239000003380 propellant Substances 0.000 description 1
238000002731 protein assay Methods 0.000 description 1
230000022558 protein metabolic process Effects 0.000 description 1
230000006337 proteolytic cleavage Effects 0.000 description 1
108010051009 proto-oncogene protein Pbx3 Proteins 0.000 description 1
230000002685 pulmonary effect Effects 0.000 description 1
238000011002 quantification Methods 0.000 description 1
238000012207 quantitative assay Methods 0.000 description 1
239000001397 quillaja saponaria molina bark Substances 0.000 description 1
238000001525 receptor binding assay Methods 0.000 description 1
230000003830 regulated secretory pathway Effects 0.000 description 1
230000014493 regulation of gene expression Effects 0.000 description 1
230000029964 regulation of glucose metabolic process Effects 0.000 description 1
230000000717 retained effect Effects 0.000 description 1
229930002330 retinoic acid Natural products 0.000 description 1
150000004492 retinoid derivatives Chemical class 0.000 description 1
229960003471 retinol Drugs 0.000 description 1
235000020944 retinol Nutrition 0.000 description 1
239000011607 retinol Substances 0.000 description 1
108010042033 retinol dehydrogenase 5 Proteins 0.000 description 1
238000012552 review Methods 0.000 description 1
CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
229940081974 saccharin Drugs 0.000 description 1
235000019204 saccharin Nutrition 0.000 description 1
239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
229930182490 saponin Natural products 0.000 description 1
150000007949 saponins Chemical class 0.000 description 1
238000012216 screening Methods 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
238000000926 separation method Methods 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
239000007787 solid Substances 0.000 description 1
108010068659 somatostatin 25 Proteins 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
239000007921 spray Substances 0.000 description 1
238000003153 stable transfection Methods 0.000 description 1
239000008107 starch Substances 0.000 description 1
235000019698 starch Nutrition 0.000 description 1
230000001954 sterilising effect Effects 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
239000003270 steroid hormone Substances 0.000 description 1
229960005322 streptomycin Drugs 0.000 description 1
229960001052 streptozocin Drugs 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
150000005846 sugar alcohols Polymers 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
230000009469 supplementation Effects 0.000 description 1
230000001502 supplementing effect Effects 0.000 description 1
239000002511 suppository base Substances 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
239000003765 sweetening agent Substances 0.000 description 1
230000002195 synergetic effect Effects 0.000 description 1
238000007910 systemic administration Methods 0.000 description 1
238000012385 systemic delivery Methods 0.000 description 1
230000008685 targeting Effects 0.000 description 1
229960000565 tazarotene Drugs 0.000 description 1
230000002123 temporal effect Effects 0.000 description 1
229940124597 therapeutic agent Drugs 0.000 description 1
RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
229940033663 thimerosal Drugs 0.000 description 1
229960004072 thrombin Drugs 0.000 description 1
229960002175 thyroglobulin Drugs 0.000 description 1
239000003053 toxin Substances 0.000 description 1
231100000765 toxin Toxicity 0.000 description 1
108700012359 toxins Proteins 0.000 description 1
230000001131 transforming effect Effects 0.000 description 1
238000013519 translation Methods 0.000 description 1
229960001727 tretinoin Drugs 0.000 description 1
150000003626 triacylglycerols Chemical class 0.000 description 1
230000001960 triggered effect Effects 0.000 description 1
241001430294 unidentified retrovirus Species 0.000 description 1
238000001291 vacuum drying Methods 0.000 description 1
238000009777 vacuum freeze-drying Methods 0.000 description 1
230000002792 vascular Effects 0.000 description 1
210000001631 vena cava inferior Anatomy 0.000 description 1
239000008215 water for injection Substances 0.000 description 1
230000003442 weekly effect Effects 0.000 description 1
230000004580 weight loss Effects 0.000 description 1